Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
...
21
22
23
24
25
26
27
28
Next >
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
March 24, 2022
Tickers
AHPA
APLS
ASND
ATHA
Tags
MRK
Offerings
ASND
From
Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
March 22, 2022
Tickers
FUSN
LNTH
NVS
PNT
Tags
Penny Stocks
NVS
Market News
From
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
March 22, 2022
Tickers
ADMP
AGTC
ANAB
APTO
Tags
ADMP
PFE
Small Cap
From
Benzinga
Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22
March 22, 2022
Tickers
BABA
BYDDY
CP
FB
Tags
GOOG
BABA
$BTC
From
Benzinga
Novartis Suspends Some Investment, Business Activities In Russia
March 22, 2022
Tickers
NVS
Tags
Ukraine/Russia War
NVS
Health Care
From
Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
Tickers
AAPL
AMC
AZN
BABA
Tags
FR:SAN
DK:ALK/B
TSLA
From
MarketWatch
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
March 19, 2022
Tickers
NVS
PFE
VYGR
Tags
Recent Press Releases
Market News
VYGR
From
Motley Fool
2 Top Stocks to Buy in March and Hold Forever
March 15, 2022
Tickers
NVS
RHHBY
VIVO
Tags
RHHBY
NVS
Recent Press Releases
From
Motley Fool
Novartis's Data Reinforces Age-Appropriate Development With Zolgensma Gene Therapy Study
March 14, 2022
Tickers
NVS
Tags
Movers
NVS
Market News
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
Market News
Health Care
NVS
From
Benzinga
Why Another ADHD Stimulant? Cingulate Inc. Believes It's All About The Timing
March 14, 2022
Tickers
CING
JNJ
NVS
Tags
Benzinga
Cingulate Therapeutics
Partner Content
From
Benzinga
3 No-Brainer Stocks to Buy With $1,000 Right Now
March 14, 2022
Tickers
CRSP
LLY
NVS
VRTX
Tags
Recent Press Releases
LLY
Market News
From
Motley Fool
Hutchmed Roils Markets With Changing of Its Guard, U.S. Delisting Threat
March 11, 2022
Tickers
HCM
JNJ
NVS
Tags
Benzinga
NVS
HCM
From
Benzinga
NEJM Publication Shows Novartis' Kisqali With Longest Median Overall Survival In Breast Cancer Setting
March 10, 2022
Tickers
NVS
Tags
breast cancer
NVS
Health Care
From
Benzinga
7 Drug Stocks To Consider After the Viatris Plunge
March 10, 2022
Tickers
ABBV
BMY
GSK
JNJ
Tags
PFE
Market News
VTRS
From
InvestorPlace
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
March 08, 2022
Tickers
ADMA
ANIK
AQST
AXDX
Tags
AXDX
NSPR
Market News
From
Benzinga
Voyager Therapeutics Shares Jump On Novartis Option Agreement For Gene Therapy Programs
March 08, 2022
Tickers
NVS
VYGR
Tags
Briefs
VYGR
Health Care
From
Benzinga
Pharmaceutical Companies Are Reportedly Refocusing On Mysterious Rise In Shingles Infections As COVID Declines
March 07, 2022
Tickers
GSK
NNVC
NVS
Tags
NVS
NNVC
Market News
From
Benzinga
Viatris Just Snagged a Major FDA Approval
March 03, 2022
Tickers
ABBV
NVS
REGN
RHHBY
Tags
REGN
SNY
Recent Press Releases
From
Motley Fool
Consumer Spending, E-Commerce, and the Business of Lodging
March 02, 2022
Tickers
ABBV
ABNB
ABT
AGN
Tags
H
DIS
ABBV
From
Motley Fool
36 Stocks To Watch After Biden's First State of The Union Address
March 02, 2022
Tickers
ABBV
ABT
AMGN
AOUT
Tags
Penny Stocks
NVS
State of the Union
From
Benzinga
This Biotech Company Reports Making Ground-Breaking Strides In Combating Solid Tumors
February 23, 2022
Tickers
BMY
NVS
ONCY
PFE
Tags
BMY
NVS
Penny Stocks
From
Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
February 18, 2022
Tickers
AGIO
AZN
BMY
GMED
Tags
NVS
Market News
SWAV
From
Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
February 18, 2022
Tickers
ANY
NVS
REGN
RHHBF
Tags
General
REGN
ANY
From
Benzinga
New FDA program could boost drug development for rare diseases
February 15, 2022
Tickers
NVS
PFE
PJP
Tags
PJP
PFE
NVS
From
MarketWatch
3 High-Yield Dividend Stocks to Buy and Hold for Decades
February 12, 2022
Tickers
BCE
KHC
NVS
WMT
Tags
BCE
Market News
Recent Press Releases
From
Motley Fool
Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B
February 10, 2022
Tickers
ALNY
NVS
REGN
Tags
Earnings
Health Care
REGN
From
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Tickers
AGLE
ALNY
ALVR
ARMP
Tags
Biotech
LLY
TWST
From
Benzinga
Molecular Partners, Novartis Submit Emergency Use Authorization Request For Ensovibep For COVID-19
February 10, 2022
Tickers
MOLN
NVS
Tags
MOLN
NVS
Health Care
From
Benzinga
Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?
February 03, 2022
Tickers
ABBV
AMGN
BMY
CANF
Tags
General
Biotech
Benzinga
From
Benzinga
< Previous
1
2
...
21
22
23
24
25
26
27
28
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit